David Einhorn: portfolio of Greenlight Capital

David Einhorn leads Greenlight Capital, which follows a value approach; short sales do not appear in the 13F report.

Source: 13F filing with the US Securities and Exchange Commission dated May 16, 2022. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q1 2022. Go to the latest filing (Q3 2026)

1.6B USDQ1 2022
Total value of stock positions
1.6B USD
Positions
52
Share of the ten largest
69.7%

The ten largest positions Q1 2022

  1. Green Brick Partners Inc 21.4%▼ −2.2%
  2. Brighthouse Finl Inc 11.9%▼ −4.0%
  3. Teck Resources Ltd 7.6%▼ −12.4%
  4. Change Healthcare Inc 5.2%▲ +3.0%
  5. Atlas Air Worldwide HLDGS In 4.6%▲ +3.8%
  6. Global Payments 4.4%unchanged
  7. Chemours Co 4.3%▲ +23.0%
  8. The Odp Corp 4.1%▼ −2.3%
  9. Consol Energy Inc New 3.5%▼ −21.4%
  10. Discovery Inc 2.6%▲ +153.4%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 8.0B USD).
Choose a quarter (54 filings)

All positions Q1 2022

Positions Q1 2022 per 13F filing, 11 of 11
Symbol Weight Shares Reported value Change Held since
Change Healthcare Inc 5.2% 3,745,705 81.7M USD +3.0% increased Q1 2020 9 quarters
Atlas Air Worldwide HLDGS In 4.6% 846,000 73.1M USD +3.8% increased Q2 2020 8 quarters
Chemours Co 4.3% 2,141,814 67.4M USD +23.0% increased Q2 2019 12 quarters
Discovery Inc 2.6% 1,652,000 41.2M USD +153.4% increased Q4 2021 2 quarters
Resideo Technologies Inc 2.3% 1,513,383 36.1M USD +29.4% increased Q2 2020 8 quarters
Livanova PLC 2.3% 440,000 36.0M USD +29.0% increased Q2 2021 4 quarters
SPDR Gold TR 2.1% 183,375 33.1M USD +58.2% increased Q2 2020 8 quarters
Kyndryl HLDGS Inc 2.0% 2,420,400 31.8M USD +162.4% increased Q4 2021 2 quarters
Civitas Resources Inc 1.1% 278,218 16.6M USD +135.3% increased Q4 2021 2 quarters
Gulfport Energy Corp 0.6% 113,136 10.2M USD +6.7% increased Q2 2021 4 quarters
Talis Biomedical Corp 0.2% 2,235,783 3.2M USD +42.5% increased Q4 2021 2 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Breakdown by sector

  • Financials 4.4%
  • Technology 1.0%
  • Communication Services 0.5%
  • not in our coverage 94.1%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close